Head-To-Head Analysis: Holdco Nuvo Group D.G (NASDAQ:NUVO) vs. Daxor (NASDAQ:DXR)

Daxor (NASDAQ:DXR) and Holdco Nuvo Group D.G (NASDAQ:NUVO) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk and analyst recommendations.

Risk and Volatility

Daxor has a beta of -0.55, suggesting that its share price is 155% less volatile than the S&P 500. Comparatively, Holdco Nuvo Group D.G has a beta of -0.28, suggesting that its share price is 128% less volatile than the S&P 500.

Insider & Institutional Ownership

1.3% of Daxor shares are owned by institutional investors. 59.0% of Daxor shares are owned by insiders. Comparatively, 24.2% of Holdco Nuvo Group D.G shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Daxor and Holdco Nuvo Group D.G’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Daxor	N/A	N/A	N/A
Holdco Nuvo Group D.G	N/A	N/A	-39.84%

Earnings and Valuation

This table compares Daxor and Holdco Nuvo Group D.G”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Daxor	N/A	N/A	N/A	N/A	N/A
Holdco Nuvo Group D.G	$180,000.00	31.41	-$33.65 million	N/A	N/A

Daxor has higher earnings, but lower revenue than Holdco Nuvo Group D.G.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Daxor and Holdco Nuvo Group D.G, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Daxor	0	0	1	0	3.00
Holdco Nuvo Group D.G	0	0	0	0	N/A

Daxor currently has a consensus target price of $24.75, suggesting a potential upside of 187.79%. Given Daxor’s higher possible upside, research analysts clearly believe Daxor is more favorable than Holdco Nuvo Group D.G.

Summary

Daxor beats Holdco Nuvo Group D.G on 5 of the 7 factors compared between the two stocks.

About Daxor

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.

About Holdco Nuvo Group D.G

LAMF Global Ventures Corp. I is a blank check company. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or related business combination with one or more businesses. LAMF Global Ventures Corp. I is based in West Hollywood, California.